{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:07:26Z","timestamp":1788232046771,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-005"],"award-info":[{"award-number":["2022-PUMCH-B-005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"DOI":"10.1007\/s00384-024-04801-w","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T08:07:53Z","timestamp":1739779673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Predictive value of rectal MRI variables for pathological complete response in locally advanced rectal cancer following neoadjuvant chemoradiotherapy"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2576-1100","authenticated-orcid":false,"given":"Ganbin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0629-9440","authenticated-orcid":false,"given":"Yang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9244-9344","authenticated-orcid":false,"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1590-6675","authenticated-orcid":false,"given":"Chentong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1494-9068","authenticated-orcid":false,"given":"Xiaoyuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guannan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beizhan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9444-1733","authenticated-orcid":false,"given":"Lai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0206-621X","authenticated-orcid":false,"given":"Junyang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0413-6987","authenticated-orcid":false,"given":"Bin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4309-1227","authenticated-orcid":false,"given":"Yi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6225-3028","authenticated-orcid":false,"given":"Guole","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"issue":"10","key":"4801_CR1","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.6004\/jnccn.2022.0051","volume":"20","author":"AB Benson","year":"2022","unstructured":"Benson AB, Venook AP, Al-Hawary MM, Azad N, Chen YJ, Ciombor KK et al (2022) Rectal cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 20(10):1139\u201367. https:\/\/doi.org\/10.6004\/jnccn.2022.0051","journal-title":"J Natl Compr Canc Netw."},{"key":"4801_CR2","doi-asserted-by":"publisher","unstructured":"(2023) Chinese protocol of diagnosis and treatment of colorectal cancer of the National Health Commission (2023 edition). Zhonghua Wei Chang Wai Ke Za Zhi 26(6):505-28. https:\/\/doi.org\/10.3760\/cma.j.cn441530-20230525-00182","DOI":"10.3760\/cma.j.cn441530-20230525-00182"},{"issue":"34","key":"4801_CR3","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1200\/jco.18.02309","volume":"37","author":"Y Deng","year":"2019","unstructured":"Deng Y, Chi P, Lan P, Wang L, Chen W, Cui L et al (2019) Neoadjuvant modified FOLFOX6 with or without radiation versus fluorouracil plus radiation for locally advanced rectal cancer: final results of the Chinese FOWARC trial. J Clin Oncol 37(34):3223\u20133233. https:\/\/doi.org\/10.1200\/jco.18.02309","journal-title":"J Clin Oncol"},{"issue":"1","key":"4801_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s1470-2045(20)30555-6","volume":"22","author":"RR Bahadoer","year":"2021","unstructured":"Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EM et al (2021) Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol 22(1):29\u201342. https:\/\/doi.org\/10.1016\/s1470-2045(20)30555-6","journal-title":"Lancet Oncol"},{"issue":"25","key":"4801_CR5","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","volume":"386","author":"A Cercek","year":"2022","unstructured":"Cercek A, Lumish M, Sinopoli J, Weiss J, Shia J, Lamendola-Essel M et al (2022) PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer. N Engl J Med 386(25):2363\u20132376. https:\/\/doi.org\/10.1056\/NEJMoa2201445","journal-title":"N Engl J Med"},{"key":"4801_CR6","doi-asserted-by":"publisher","unstructured":"Lin ZY, Zhang P, Chi P, Xiao Y, Xu XM, Zhang AM et al (2024) Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy in locally advanced rectal cancer (UNION): early outcomes of a multicenter randomized phase III trial. Ann Oncol. https:\/\/doi.org\/10.1016\/j.annonc.2024.06.015","DOI":"10.1016\/j.annonc.2024.06.015"},{"issue":"2","key":"4801_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/sla.0000000000004499","volume":"276","author":"AC Lord","year":"2022","unstructured":"Lord AC, D\u2019Souza N, Shaw A, Rokan Z, Moran B, Abulafi M et al (2022) MRI-diagnosed tumor deposits and EMVI status have superior prognostic accuracy to current clinical TNM staging in rectal cancer. Ann Surg 276(2):334\u2013344. https:\/\/doi.org\/10.1097\/sla.0000000000004499","journal-title":"Ann Surg"},{"issue":"7","key":"4801_CR8","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1245\/s10434-023-13225-9","volume":"30","author":"HM Thompson","year":"2023","unstructured":"Thompson HM, Bates DDB, Pernicka JG, Park SJ, Nourbakhsh M, Fuqua JL 3rd et al (2023) MRI assessment of extramural venous invasion before and after total neoadjuvant therapy for locally advanced rectal cancer and its association with disease-free and overall survival. Ann Surg Oncol 30(7):3957\u20133965. https:\/\/doi.org\/10.1245\/s10434-023-13225-9","journal-title":"Ann Surg Oncol"},{"key":"4801_CR9","doi-asserted-by":"publisher","first-page":"1361300","DOI":"10.3389\/fonc.2024.1361300","volume":"14","author":"X Zhong","year":"2024","unstructured":"Zhong X, Zeng G, Zhang L, You S, Fu Y, He W et al (2024) Prediction of pathologic complete response to neoadjuvant chemoradiation in locally advanced rectal cancer. Front Oncol 14:1361300. https:\/\/doi.org\/10.3389\/fonc.2024.1361300","journal-title":"Front Oncol"},{"issue":"6","key":"4801_CR10","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.4251\/wjgo.v16.i6.2520","volume":"16","author":"YJ Xu","year":"2024","unstructured":"Xu YJ, Tao D, Qin SB, Xu XY, Yang KW, Xing ZX et al (2024) Prediction of pathological complete response and prognosis in locally advanced rectal cancer. World J Gastrointest Oncol 16(6):2520\u20132530. https:\/\/doi.org\/10.4251\/wjgo.v16.i6.2520","journal-title":"World J Gastrointest Oncol"},{"issue":"11","key":"4801_CR11","doi-asserted-by":"publisher","first-page":"107070","DOI":"10.1016\/j.ejso.2023.107070","volume":"49","author":"J Liu","year":"2023","unstructured":"Liu J, Lee JYT, Bedrikovetski S, Traeger L, Moore JW, Perry JL et al (2023) Clinical predictors of rectal cancer response after neo-adjuvant (chemo)radiotherapy in Australia and New Zealand: analysis of the Bi-national colorectal cancer audit (BCCA). Eur J Surg Oncol 49(11):107070. https:\/\/doi.org\/10.1016\/j.ejso.2023.107070","journal-title":"Eur J Surg Oncol"},{"key":"4801_CR12","doi-asserted-by":"publisher","unstructured":"Gambacorta MA, Chiloiro G, Masciocchi C, Mariani S, Romano A, Gonnelli A et al (2023) pCR and 2-year disease-free survival: a combination of the two endpoints as a new classification for locally advanced rectal cancer patients-an updated pooled analysis of eleven international randomized trials. Cancers (Basel) 15(12). https:\/\/doi.org\/10.3390\/cancers15123209.","DOI":"10.3390\/cancers15123209"},{"issue":"1","key":"4801_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s00384-023-04330-y","volume":"38","author":"Y Yuan","year":"2023","unstructured":"Yuan Y, Zheng K, Zhou L, Chen F, Zhang S, Lu H et al (2023) Predictive value of modified MRI-based split scar sign (mrSSS) score for pathological complete response after neoadjuvant chemoradiotherapy for patients with rectal cancer. Int J Colorectal Dis 38(1):40. https:\/\/doi.org\/10.1007\/s00384-023-04330-y","journal-title":"Int J Colorectal Dis"},{"issue":"4","key":"4801_CR14","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s11547-024-01796-w","volume":"129","author":"H Shen","year":"2024","unstructured":"Shen H, Jin Z, Chen Q, Zhang L, You J, Zhang S et al (2024) Image-based artificial intelligence for the prediction of pathological complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer: a systematic review and meta-analysis. Radiol Med 129(4):598\u2013614. https:\/\/doi.org\/10.1007\/s11547-024-01796-w","journal-title":"Radiol Med"},{"issue":"1","key":"4801_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1158\/1078-0432.Ccr-20-2299","volume":"27","author":"J Zhou","year":"2021","unstructured":"Zhou J, Wang C, Lin G, Xiao Y, Jia W, Xiao G et al (2021) Serial circulating tumor DNA in predicting and monitoring the effect of neoadjuvant chemoradiotherapy in patients with rectal cancer: a prospective multicenter study. Clin Cancer Res 27(1):301\u2013310. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-20-2299","journal-title":"Clin Cancer Res"},{"issue":"5","key":"4801_CR16","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/s2468-1253(22)00439-3","volume":"8","author":"G Chen","year":"2023","unstructured":"Chen G, Jin Y, Guan WL, Zhang RX, Xiao WW, Cai PQ et al (2023) Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study. Lancet Gastroenterol Hepatol 8(5):422\u2013431. https:\/\/doi.org\/10.1016\/s2468-1253(22)00439-3","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"4801_CR17","doi-asserted-by":"publisher","first-page":"1149122","DOI":"10.3389\/fimmu.2023.1149122","volume":"14","author":"W Xiao","year":"2023","unstructured":"Xiao W, Luo H, Yao Y, Wang Y, Liu S, Sun R et al (2023) Total neoadjuvant treatment and PD-1\/PD-L1 checkpoint inhibitor in locally advanced rectal cancer. Front Immunol 14:1149122. https:\/\/doi.org\/10.3389\/fimmu.2023.1149122","journal-title":"Front Immunol"},{"issue":"11","key":"4801_CR18","doi-asserted-by":"publisher","first-page":"6263","DOI":"10.1007\/s00330-020-06968-6","volume":"30","author":"H Shaish","year":"2020","unstructured":"Shaish H, Aukerman A, Vanguri R, Spinelli A, Armenta P, Jambawalikar S et al (2020) Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study. Eur Radiol 30(11):6263\u20136273. https:\/\/doi.org\/10.1007\/s00330-020-06968-6","journal-title":"Eur Radiol"},{"issue":"12","key":"4801_CR19","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/j.1463-1318.2011.02570.x","volume":"13","author":"HZ Qiu","year":"2011","unstructured":"Qiu HZ, Wu B, Xiao Y, Lin GL (2011) Combination of differentiation and T stage can predict unresponsiveness to neoadjuvant therapy for rectal cancer. Colorectal Dis 13(12):1353\u20131360. https:\/\/doi.org\/10.1111\/j.1463-1318.2011.02570.x","journal-title":"Colorectal Dis"},{"issue":"4","key":"4801_CR20","doi-asserted-by":"publisher","first-page":"108001","DOI":"10.1016\/j.ejso.2024.108001","volume":"50","author":"Y Cai","year":"2024","unstructured":"Cai Y, Chen M, Ye F, Liu Z, Luo S, Huang L et al (2024) The clinical relevance of adjuvant chemotherapy in locally advanced rectal cancer patients achieving near pathological complete response following neoadjuvant chemoradiotherapy: insights from ypT stage. Eur J Surg Oncol 50(4):108001. https:\/\/doi.org\/10.1016\/j.ejso.2024.108001","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"4801_CR21","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1245\/s10434-015-5017-y","volume":"23","author":"E Al-Sukhni","year":"2016","unstructured":"Al-Sukhni E, Attwood K, Mattson DM, Gabriel E, Nurkin SJ (2016) Predictors of pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer. Ann Surg Oncol 23(4):1177\u20131186. https:\/\/doi.org\/10.1245\/s10434-015-5017-y","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"4801_CR22","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1245\/s10434-017-5873-8","volume":"24","author":"PD Lorimer","year":"2017","unstructured":"Lorimer PD, Motz BM, Kirks RC, Boselli DM, Walsh KK, Prabhu RS et al (2017) Pathologic complete response rates after neoadjuvant treatment in rectal cancer: an analysis of the national cancer database. Ann Surg Oncol 24(8):2095\u20132103. https:\/\/doi.org\/10.1245\/s10434-017-5873-8","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"4801_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3760\/cma.j.issn.0253-2727.2019.01.010","volume":"40","author":"J Wu","year":"2019","unstructured":"Wu J, Lu AD, Zhang LP, Zuo YX, Jia YP (2019) Study of clinical outcome and prognosis in pediatric core binding factor-acute myeloid leukemia. Zhonghua Xue Ye Xue Za Zhi 40(1):52\u201357. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2019.01.010","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"3","key":"4801_CR24","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1463-1318.2008.01593.x","volume":"11","author":"A Suppiah","year":"2009","unstructured":"Suppiah A, Hunter IA, Cowley J, Garimella V, Cast J, Hartley JE et al (2009) Magnetic resonance imaging accuracy in assessing tumour down-staging following chemoradiation in rectal cancer. Colorectal Dis 11(3):249\u2013253. https:\/\/doi.org\/10.1111\/j.1463-1318.2008.01593.x","journal-title":"Colorectal Dis"},{"issue":"2","key":"4801_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/08941939.2019.1615153","volume":"34","author":"W Liu","year":"2021","unstructured":"Liu W, Li Y, Zhu H, Pei Q, Tan F, Song X et al (2021) The relationship between primary gross tumor volume and tumor response of locally advanced rectal cancer: pGTV as a more accurate tumor size indicator. J Invest Surg 34(2):181\u2013190. https:\/\/doi.org\/10.1080\/08941939.2019.1615153","journal-title":"J Invest Surg"},{"issue":"7","key":"4801_CR26","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.ejso.2019.03.005","volume":"45","author":"Y Sun","year":"2019","unstructured":"Sun Y, Wu X, Zhang Y, Lin H, Lu X, Huang Y et al (2019) Pathological complete response may underestimate distant metastasis in locally advanced rectal cancer following neoadjuvant chemoradiotherapy and radical surgery: incidence, metastatic pattern, and risk factors. Eur J Surg Oncol 45(7):1225\u20131231. https:\/\/doi.org\/10.1016\/j.ejso.2019.03.005","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"4801_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/coc.0000000000000942","volume":"45","author":"F Yang","year":"2022","unstructured":"Yang F, Hill J, Abraham A, Ghosh S, Steed T, Kurtz C et al (2022) Tumor volume predicts for pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation. Am J Clin Oncol 45(10):405\u2013409. https:\/\/doi.org\/10.1097\/coc.0000000000000942","journal-title":"Am J Clin Oncol"},{"issue":"9","key":"4801_CR28","doi-asserted-by":"publisher","first-page":"e233","DOI":"10.1016\/j.acra.2019.10.021","volume":"27","author":"Y Meng","year":"2020","unstructured":"Meng Y, Wan L, Zhang C, Wang C, Ye F, Li S et al (2020) The predictive value of pre-\/postneoadjuvant chemoradiotherapy MRI characteristics for patient outcomes in locally advanced rectal cancer. Acad Radiol 27(9):e233\u2013e243. https:\/\/doi.org\/10.1016\/j.acra.2019.10.021","journal-title":"Acad Radiol"},{"issue":"4","key":"4801_CR29","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/sla.0000000000005780","volume":"277","author":"WJ Mei","year":"2023","unstructured":"Mei WJ, Wang XZ, Li YF, Sun YM, Yang CK, Lin JZ et al (2023) Neoadjuvant chemotherapy with CAPOX versus chemoradiation for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): initial results of a phase III trial. Ann Surg 277(4):557\u2013564. https:\/\/doi.org\/10.1097\/sla.0000000000005780","journal-title":"Ann Surg"},{"issue":"1","key":"4801_CR30","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1186\/s12885-023-11103-x","volume":"23","author":"W Zhang","year":"2023","unstructured":"Zhang W, Zhou H, Jiang J, Zhu Y, Zou S, Jiang L et al (2023) Neoadjuvant chemotherapy with modified FOLFOXIRI for locally advanced rectal cancer to transform effectively EMVI and MRF from positive to negative: results of a long-term single center phase 2 clinical trial. BMC Cancer 23(1):592. https:\/\/doi.org\/10.1186\/s12885-023-11103-x","journal-title":"BMC Cancer"},{"key":"4801_CR31","doi-asserted-by":"publisher","unstructured":"Conroy T, Castan F, Etienne PL, Rio E, Mesgouez-Nebout N, Evesque L et al (2024) Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial. Ann Oncol. https:\/\/doi.org\/10.1016\/j.annonc.2024.06.019","DOI":"10.1016\/j.annonc.2024.06.019"},{"issue":"1","key":"4801_CR32","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3748\/wjg.v25.i1.118","volume":"25","author":"DL Ren","year":"2019","unstructured":"Ren DL, Li J, Yu HC, Peng SY, Lin WD, Wang XL et al (2019) Nomograms for predicting pathological response to neoadjuvant treatments in patients with rectal cancer. World J Gastroenterol 25(1):118\u2013137. https:\/\/doi.org\/10.3748\/wjg.v25.i1.118","journal-title":"World J Gastroenterol"},{"issue":"21","key":"4801_CR33","doi-asserted-by":"publisher","first-page":"20523","DOI":"10.1002\/cam4.6625","volume":"12","author":"M Chen","year":"2023","unstructured":"Chen M, Ma Y, Song YW, Huang J, Gao YH, Zheng J et al (2023) Survival outcomes of different neoadjuvant treatment regimens in patients with locally advanced rectal cancer and MRI-detected extramural venous invasion. Cancer Med 12(21):20523\u201320537. https:\/\/doi.org\/10.1002\/cam4.6625","journal-title":"Cancer Med"},{"issue":"6","key":"4801_CR34","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.1007\/s00330-023-10300-3","volume":"34","author":"SY Yang","year":"2024","unstructured":"Yang SY, Bae H, Seo N, Han K, Han YD, Cho MS et al (2024) Pretreatment MRI-detected extramural venous invasion as a prognostic and predictive biomarker for neoadjuvant chemoradiotherapy in non-metastatic rectal cancer: a propensity score matched analysis. Eur Radiol 34(6):3686\u20133698. https:\/\/doi.org\/10.1007\/s00330-023-10300-3","journal-title":"Eur Radiol"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-024-04801-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-024-04801-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-024-04801-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T08:08:00Z","timestamp":1739779680000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-024-04801-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4801"],"URL":"https:\/\/doi.org\/10.1007\/s00384-024-04801-w","relation":{},"ISSN":["1432-1262"],"issn-type":[{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"28 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}